27 days ago • Posted by William Ramstein

New regulation and macro concerns sees Biotech stocks nosediving

The biotech SPDR S&P benchmark has taken a nosedive during the past month. New biotech IPOs will be a key barometer for investor appetite going forward.

Source: Bloomberg

bg_nwsletter